Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP608103.RAmocPeA6G2tdaVd02yqJcia0Ehb_CbTk2JWjdarGLwVE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP608103.RAmocPeA6G2tdaVd02yqJcia0Ehb_CbTk2JWjdarGLwVE130_assertion type Assertion NP608103.RAmocPeA6G2tdaVd02yqJcia0Ehb_CbTk2JWjdarGLwVE130_head.
- NP608103.RAmocPeA6G2tdaVd02yqJcia0Ehb_CbTk2JWjdarGLwVE130_assertion description "[In the training set, PAK1 levels were associated with tumor progression after tamoxifen (HR 1.57, 95% CI 0.99-2.48), as was co-expression of PKA and ER?S305-P (HR 2.00, 95% CI 1.14-3.52).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP608103.RAmocPeA6G2tdaVd02yqJcia0Ehb_CbTk2JWjdarGLwVE130_provenance.
- NP608103.RAmocPeA6G2tdaVd02yqJcia0Ehb_CbTk2JWjdarGLwVE130_assertion evidence source_evidence_literature NP608103.RAmocPeA6G2tdaVd02yqJcia0Ehb_CbTk2JWjdarGLwVE130_provenance.
- NP608103.RAmocPeA6G2tdaVd02yqJcia0Ehb_CbTk2JWjdarGLwVE130_assertion SIO_000772 20213082 NP608103.RAmocPeA6G2tdaVd02yqJcia0Ehb_CbTk2JWjdarGLwVE130_provenance.
- NP608103.RAmocPeA6G2tdaVd02yqJcia0Ehb_CbTk2JWjdarGLwVE130_assertion wasDerivedFrom befree-20150227 NP608103.RAmocPeA6G2tdaVd02yqJcia0Ehb_CbTk2JWjdarGLwVE130_provenance.
- NP608103.RAmocPeA6G2tdaVd02yqJcia0Ehb_CbTk2JWjdarGLwVE130_assertion wasGeneratedBy ECO_0000203 NP608103.RAmocPeA6G2tdaVd02yqJcia0Ehb_CbTk2JWjdarGLwVE130_provenance.